Skip to Content

Grant Support

Capitini, Christian Matthew St Baldricks Foundation St. Baldrick's Foundation Summer Fellowship Award
Capitini, Christian Matthew American Cancer Society Monitoring of 19F-Labeled NK Cell Trafficking for Cancer Immunotherapy Using MRI
Capitini, Christian Matthew Midwest Athletes Against Childhood Cancer Inhibiting STAT1 as a Platform for GVHD Resistance and Preservation of GVL
Desantes, Kenneth Midwest Athletes Against Childhood Cancer Support for Research Data Management
Desantes, Kenneth Solving Kids Cancer Reduced Intensity Haploidentical Transplantation with NK Cell Infusion for Pediatric Acute Leukemia and High Risk Solid Tumors
Desantes, Kenneth Midwest Athletes Against Childhood Cancer Reduced Intensity Haploidentical Transplantation with NK Cell Infusions for Pediatric Acute Leukemia and High Risk Solid Tumors
Desantes, Kenneth Children's Hospital of Philadelphia COG–AALL1122
Desantes, Kenneth Children's Hospital of Philadelphia COG Per Case & Specimen Reimbursement
Desantes, Kenneth Children's Hospital of Philadelphia St. Baldrick's Supplemental Per Case Reimbursement (COG)
Desantes, Kenneth Solving Kids Cancer Phase I Trial of Ex-Vivo Expanded Haploidentical NK Cells and Hu14.18-IL2 for Children with Relapsed/Refractory Neuroblastoma
Desantes, Kenneth Children's Hospital of Philadelphia A Phase III Randomized Trial for Patients with de novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD - AAML1031
Desantes, Kenneth Children's Hospital of Philadelphia AALL07P1 - A Phase II Pilot Trial of Bortezomib (PS-341, VELCADE IND 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
Desantes, Kenneth Midwest Athletes Against Childhood Cancer Alpha/Beta T-Cell Depleted Haploidentical Transplantation with Post-Transplant Zoledronic Acid to Treat Recurrent or Refractory Pediatric Malignancies
Desantes, Kenneth Children's Hospital of Philadelphia CCOP: COG Per Case Reimbursement
Desantes, Kenneth Children's Hospital of Philadelphia 11 TREO
Desantes, Kenneth Children's Hospital of Philadelphia PIDTC Per Case Reimbursement
Desantes, Kenneth Children's Hospital of Philadelphia COG Chair's Grant/Workload Intensity
Desantes, Kenneth Children's Hospital of Philadelphia A Phase II Study of MLN8237 (IND#102984), a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias (ADVL0921)
Desantes, Kenneth Children's Hospital of Philadelphia ANBL0532 CTSU Per Case Reimbursement
Diamond, Carol A CDC Foundation Universal Data Collection Project for Blood Inhibitor Study
Otto, Mario Midwest Athletes Against Childhood Cancer Development of Multifunctional Superparamagnetic anti-GD2 Nanoparticles for Simultaneous Molecular Imaging, Cancer Cell Targeting and Drug Delivery
Otto, Mario Alex’s Lemonade Stand Foundation Development of an Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ether Analogue and Its Multifunctional Cancer-Targeting Nanoconstruct
Puccetti, Diane Midwest Athletes Against Childhood Cancer Psychosocial Aspects of Ending Treatment & Long-Term Survival of Pediatric Cancer Patients: A Joint Proposal
Puccetti, Diane OSI Pharmaceuticals, Inc. OSI 774 206
Sondel, Paul Midwest Athletes Against Childhood Cancer Neuroblastoma Tumor Escape Variants Modulate MHC Class I Expression in Response to NK- or T Cell- Mediated Immunotherapy
Sondel, Paul St Jude Medical A Phase I Trial of the Humanized Anti-GD2 Antibody (HU14.18K322A) in Children and Adolescents with Neuroblastoma or Melanoma
Sondel, Paul St Jude Medical A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (Hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in Children and Adolescents with Recurrent / Refractory Neuroblastoma
Sondel, Paul Stand Up To Cancer / St. Baldrick’s Foundation SU2C Dream Team
Sondel, Paul Hyundai Hope On Wheels Novel Modification of Anti-GD2 Immunocytokine Design and Delivery Regimens to Augment T-cell Involvement and Boost Anti-Neuroblastoma Efficacy
Sondel, Paul Children's Hospital of Philadelphia COG Sci. Leadership 2013-14
Sondel, Paul DHHS, PHS, National Institutes of Health Antitumor Mechanisms of alpha-CD40/CpG-activated Macrophages
Sondel, Paul DHHS, PHS, National Institutes of Health Clinical Development of HU14.18-IL2 Targeted Therapy
Sondel, Paul DHHS, PHS, National Institutes of Health The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy
Sondel, Paul Wisconsin Alumni Research Foundation In Vivo Preclinical Analyses of Molecular Variants of TKIs Designed to Prevent Immune Suppression
Sondel, Paul Wisconsin Alumni Research Foundation In Vitro Analyses of Molecular Variants of TKIs Designed to Prevent Immune Suppression
Sondel, Paul UWMF–UW Medical Foundation In Depth Delineation of FCIRIIA Genotypes and Potential Clinical Implications
Sondel, Paul Radiation Society of North America Synergy of Radiation and immunotherapy in the Treatment of Melanoma
Sondel, Paul NCI-Cancer Immunotherapy Trials Network Cancer Immunotherapy Trials Network Consortium

Last updated: 03/12/2014
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2014 The Board of Regents of the University of Wisconsin System